Patents by Inventor Xueping ZHANG

Xueping ZHANG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI-MASP-2 ANTIBODY AND USE THEREOF
    Publication number: 20240141069
    Abstract: An anti-MASP-2 antibody and use thereof. The anti-MASP-2 antibody specifically binds to a human MASP-2 protein at a KD value of about 2E-09M or less, and the anti-MASP-2 antibody specifically binds to a cynomolgus monkey MASP-2 protein at a KD value of about 2E-09M or less. Disclosed are an immunoconjugate containing the anti-MASP-2 antibody, a method for preparing the anti-MASP-2 antibody, and use of the anti-MASP-2 antibody.
    Type: Application
    Filed: June 7, 2022
    Publication date: May 2, 2024
    Inventors: Xiaowu LIU, Xiaodan CAO, Jianqiu SONG, Zongda WANG, Peipei LIU, Jianjian ZHANG, Chunyin GU, Sujun DENG, Zhongzong PAN, Xueping WANG
  • ANTIBODIES AGAINST HUMAN TSLP AND USE THEREOF
    Publication number: 20240132581
    Abstract: A bispecific antibody and a monoclonal antibody against human thymic stromal lymphopoietin (TSLP), and a use thereof.
    Type: Application
    Filed: June 16, 2021
    Publication date: April 25, 2024
    Inventors: Xueping ZHANG, Zhigang LIU, Xiaowei ZHOU, Junjie HU, Xiaobo HAO, Yulan LIU
  • GARP Protein Antibody and Use Thereof
    Publication number: 20240117034
    Abstract: Provided is an GARP protein antibody, and a cell comprising or expressing the GA RP protein antibody. The GARP protein antibody binds to human GARP/human TGF-?1 complex with a KD value of about 1.0E-12 or less. Also provided are a pharmaceutical combination comprising the GARP protein antibody and an immune checkpoint inhibitor and use thereof.
    Type: Application
    Filed: January 17, 2022
    Publication date: April 11, 2024
    Applicants: SHANGHAI JEMINCARE PHARMACEUTICAL CO., LTD., JIANGXI JEMINCARE GROUP CO., LTD.
    Inventors: Jianjian ZHANG, Zhongzong PAN, Xinxiu YANG, Xiaowu LIU, Lu YANG, Peipei LIU, Xiaodan CAO, Sujun DENG, Xueping WANG
  • ANTI-CD3 and ANTI-CD123 Bispecific Antibody and Use Thereof
    Publication number: 20230071422
    Abstract: Provided is a bispecific antibody comprising an antigen-binding portion for human CD3E and/or an antigen-binding portion for human CD123. Further provided are the medical and biological uses of the bispecific antibody.
    Type: Application
    Filed: March 30, 2020
    Publication date: March 9, 2023
    Inventors: Zhigang Liu, Xiaobo HAO, Xueping ZHANG, Yulan LIU, Jingjing GUO